Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rapidly progressive glomerulonephritis with extensive glomerular crescent formation.

G H Neild, J S Cameron, C S Ogg

    The Quarterly Journal of Medicine
    |January 1, 1983
    PubMed
    Summary

    Severe crescentic glomerulonephritis requires prompt treatment. Early intervention with corticosteroids and immunosuppressants improved renal function outcomes in patients with rapidly progressive renal failure.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Influence of comorbidities on transplant outcomes in patients aged 50 years or more after myeloablative conditioning incorporating fludarabine, BU and ATG.

    Bone marrow transplantation·2010
    Same author

    Fibrinopeptide A, Thromboxane B(2) and Beta-thromboglobulin Levels in Bleeding Time Blood in Uraemia.

    Platelets·2010
    Same author

    A feasibility, pharmacokinetic and frequency-escalation trial of intraperitoneal chemotherapy in high risk gastrointestinal tract cancer.

    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2007
    Same author

    Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.

    Clinical nephrology·2006
    Same author

    Neural crest migration and mouse models of congenital heart disease.

    Cold Spring Harbor symposia on quantitative biology·2003
    Same author

    Confidentiality and the duties of care.

    Journal of medical ethics·2003

    Area of Science:

    • Nephrology
    • Internal Medicine
    • Pathology

    Background:

    • Severe crescentic glomerulonephritis (CGN) is a critical condition leading to rapidly progressive renal failure.
    • CGN presents with diverse clinical and histological patterns, impacting patient prognosis.
    • Multi-system disease and specific glomerulonephritis types influence disease presentation and severity.

    Purpose of the Study:

    • To review outcomes of patients with severe CGN and rapidly progressive renal failure.
    • To identify prognostic factors and evaluate treatment efficacy in CGN.
    • To understand the long-term renal function and survival rates in this patient cohort.

    Main Methods:

    • Retrospective review of 39 patients with severe CGN and rapidly progressive renal failure.

    Related Experiment Videos

  • Analysis of clinical presentation, renal biopsy findings (focal necrotizing glomerulonephritis, proliferative glomerulonephritis with crescents), and multi-system involvement.
  • Evaluation of treatment protocols including high-dose corticosteroids, azathioprine, and anticoagulants, correlated with patient outcomes.

    • Main Results:

    • Renal function at admission was the most significant prognostic indicator; only 4/21 dialysis patients recovered function.
    • Patients with necrotizing glomerulonephritis had a poorer prognosis, with two-thirds presenting with oliguria.
    • Of 18 non-oliguric patients treated aggressively, 17 retained or regained renal function, though some later experienced renal failure or died from non-renal causes.

    Conclusions:

    • Prompt treatment, including corticosteroids and immunosuppressants, may improve outcomes in severe CGN.
    • Early renal function status is a critical determinant of recovery in rapidly progressive renal failure.
    • Despite aggressive management, a significant proportion of patients with severe CGN face poor long-term renal outcomes, including death, dialysis, or transplantation.